Krishan Maggon

Krishan Maggon, PhD, a pharma/biotech R&D advisor, can be reached at +44 22 710 0970 343 3482.


The Ten Billion Dollar Molecule

Erythropoietin is marketed by different companies under different names-Epogen, Procrit, Eprex, Espo, Epogin, Aranesp, and NeRecormon-so it has never made anyone's list of best-selling drugs. But EPO is likely to be the first molecule to reach the $10 billon dollar mark in annual sales. Pfizer's Lipitor (atorvastatin) and two biologic proteins, interferon and insulin, will be hot on its heels.